Drug Overview
In the field of hematology, maintaining healthy iron levels is essential for a child’s growth, brain development, and overall energy. Icar Pediatric is a specialized medication classified within the Iron Supplement drug class. It is specifically designed to address the unique needs of infants and children who are unable to maintain adequate iron levels through diet alone.
While many traditional iron supplements use iron salts that can be harsh on a child’s stomach, Icar Pediatric utilizes Carbonyl Iron. This form of iron is highly concentrated and allows for smaller dosage volumes, which is particularly beneficial for pediatric patients who may be sensitive to the taste or volume of liquid medications.
- Generic Name: Carbonyl Iron
- US Brand Names: Icar Pediatric, NovaFerrum Pediatric, Feosol (Carbonyl version)
- Route of Administration: Oral (Liquid Suspension)
- FDA Approval Status: Regulated by the FDA as a mineral supplement; widely used under clinical guidance for the treatment of diagnosed iron deficiency in children.
What Is It and How Does It Work? (Mechanism of Action)

Icar Pediatric works by providing a pure, elemental source of iron that the body uses to build healthy blood. To understand its action at the molecular and hematological level, we must look at how Carbonyl Iron differs from standard iron salts like ferrous sulfate.
1. Molecular Structure and Solubilization
Carbonyl Iron consists of extremely small, spherical particles of nearly 100 percent pure elemental iron. Unlike iron salts, which dissolve immediately in the stomach and can release a “burst” of iron that irritates the stomach lining, Carbonyl Iron must be dissolved by the child’s natural stomach acid. This slow conversion from metallic iron to the usable ferrous form (Fe2+) results in a more gradual absorption. This gentle process significantly reduces the risk of stomach pain, nausea, and vomiting, which are common barriers to treatment in children.
2. Hematological Incorporation
Once the iron is solubilized in the stomach and moves into the small intestine, it is absorbed into the bloodstream.
- Transport: The iron binds to a protein called transferrin, which acts as a shuttle.
- Hemoglobin Production: Transferrin carries the iron to the bone marrow. Here, the iron is incorporated into the “heme” portion of hemoglobin.
- Oxygen Delivery: Hemoglobin is the protein in red blood cells that allows them to pick up oxygen from the lungs and carry it to every organ in the child’s body.
By providing this essential mineral, Icar Pediatric directly supports erythropoiesis (the creation of new red blood cells), ensuring that the child’s developing brain and muscles receive the oxygen they need to thrive.
FDA-Approved Clinical Indications
Primary Indication
The primary indication for Icar Pediatric is the treatment and prevention of pediatric iron deficiency and Iron Deficiency Anemia (IDA). In the hematology category, this medication is used to “refill” a child’s iron stores when they have become depleted. Iron deficiency in children is a serious concern as it can lead to delayed motor skills, behavioral issues, and impaired cognitive development. Icar Pediatric is utilized to restore these levels safely and effectively.
Other Approved & Off-Label Uses
- Prophylaxis in Premature Infants: Premature babies often miss the final months of iron transfer from the mother and may require early iron support.
- Restrictive Diets: Used for children with specific dietary restrictions (e.g., veganism or severe food allergies) who cannot consume enough iron-rich foods.
- Chronic Blood Loss Support: Used for children with gastrointestinal conditions that may cause slow, chronic blood loss.
Dosage and Administration Protocols
The dosage for Icar Pediatric must be strictly individualized based on the child’s weight and the severity of the deficiency as measured by blood tests. The following table provides standard clinical generalizations for elemental iron dosing.
| Age / Weight Group | Standard Dosage (Elemental Iron) | Frequency |
| Infants (under 12 months) | 1 to 3 mg/kg per day | Once daily |
| Toddlers (1 to 3 years) | 3 to 6 mg/kg per day | Once daily or divided |
| Children (4 to 12 years) | 3 to 6 mg/kg per day (Max 60mg) | Divided into 1 or 2 doses |
| Adolescents | 60 to 120 mg per day | Divided into 2 doses |
Important Adjustments:
- Weight-Based Dosing: Always calculate the dose based on the child’s current weight in kilograms (kg) rather than age alone.
- Elemental Iron Calculation: Icar Pediatric typically contains 15 mg of elemental iron per 1.25 mL. Parents must distinguish between the “volume” of the liquid and the “mg of elemental iron.”
- Renal/Hepatic Insufficiency: Children with underlying kidney or liver disease require frequent monitoring by a hematologist to prevent iron overload, as these organs help manage iron storage and byproduct filtration.
Clinical Efficacy and Research Results
Clinical data from 2020 through 2026 confirms that Carbonyl Iron is an exceptionally effective choice for pediatric hematology. Because children are prone to refusing medications that cause stomach upset, the “tolerability” of Icar Pediatric is its greatest clinical strength.
Numerical data from pediatric trials suggests that children taking Carbonyl Iron have a high “compliance rate”—meaning they are more likely to finish the full course of treatment compared to those taking ferrous sulfate. Research shows that with consistent use, a child’s hemoglobin levels typically rise by 1.0 to 2.0 g/dL within the first 4 weeks of therapy. Furthermore, clinical studies indicate that Carbonyl Iron has a much higher “LD50” (the dose that is lethal in 50 percent of cases) than iron salts, making it a safer option to keep in households with young children, although safety precautions are still mandatory.
Safety Profile and Side Effects
Black Box Warning
WARNING: ACCIDENTAL OVERDOSE OF IRON-CONTAINING PRODUCTS IS A LEADING CAUSE OF FATAL POISONING IN CHILDREN UNDER 6. KEEP THIS PRODUCT OUT OF REACH OF CHILDREN. IN CASE OF ACCIDENTAL OVERDOSE, CALL A DOCTOR OR POISON CONTROL CENTER IMMEDIATELY.
Common side effects (>10%)
- Dark Stools: Iron causes the stool to turn black or dark green; this is harmless.
- Constipation: A frequent side effect of all iron supplements.
- Mild Nausea: Occasional stomach upset, though less frequent than with other iron forms.
Serious adverse events
- Iron Toxicity: Symptoms include severe vomiting, bloody diarrhea, and extreme lethargy.
- Hypersensitivity: Rare allergic reactions including rash or itching.
- Staining of Teeth: Liquid iron can occasionally cause temporary surface staining on a child’s teeth.
Management Strategies
To manage constipation, parents should encourage increased water intake and high-fiber foods (like pears or prunes). To prevent tooth staining, the liquid can be mixed with a small amount of water or juice and given via a straw or a dropper placed toward the back of the mouth. If stomach upset occurs, the dose can be given with a small amount of food, though this may slightly reduce absorption.
Research Areas
Current pediatric research (2024-2026) is exploring “Alternate Day Dosing.” Some studies suggest that giving iron every other day instead of every day may be just as effective while significantly reducing side effects like constipation. Additionally, researchers are investigating the use of “Sucrosomial Iron” in pediatric populations—a technology that wraps iron in a protective bubble to hide it from the stomach entirely. Another active area of study is the link between iron levels and sleep disorders in children, such as Restless Legs Syndrome, to determine if Icar Pediatric can improve sleep quality in iron-deficient toddlers.
Patient Management and Practical Recommendations
Pre-treatment Tests
Before starting Icar Pediatric, the following baseline diagnostics are required:
- Complete Blood Count (CBC): To check hemoglobin (Hgb) and Mean Corpuscular Volume (MCV).
- Serum Ferritin: To measure the body’s total iron “savings account.”
- Serum Iron and TIBC: To evaluate the amount of iron circulating in the blood.
Precautions during treatment
- Vigilance: Parents should watch for a “reticulocyte response” (an increase in new red blood cells) which usually occurs 7 to 10 days after starting treatment.
- Follow-up Labs: Blood tests should be repeated every 4 to 8 weeks to ensure the dose is correct and to avoid iron overload.
“Do’s and Don’ts” List
- DO give Icar Pediatric with a small amount of Vitamin C (like a few ounces of orange juice) to help the body absorb the iron.
- DO keep a “symptom log” to track any changes in your child’s energy or stool habits.
- DO store the bottle in a high, locked cabinet that a child cannot reach.
- DON’T give iron within 2 hours of dairy products (milk, yogurt, cheese), as calcium blocks iron absorption.
- DON’T mix the iron into a full bottle of milk or a large glass of juice, as the child may not finish the whole serving and will miss their dose.
- DON’T stop the medication as soon as the blood test looks “normal.” It usually takes 3 to 6 additional months to fully replenish the body’s iron stores.
Legal Disclaimer
For informational purposes only; this guide does not replace professional medical advice from a qualified healthcare provider. Always consult your pediatrician or a pediatric hematologist for the diagnosis and treatment of iron deficiency in children.